Unknown

Dataset Information

0

Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.


ABSTRACT: DC-SIGN is an antigen uptake receptor expressed on dendritic cells (DCs) with specificity for glycans present on a broad variety of pathogens and is capable of directing its cargo to MHC-I and MHC-II pathways for the induction of CD8+ and CD4+ T cell responses, respectively. Therefore, DC-SIGN is a very promising target for the delivery of antigen for anti-cancer vaccination. Although the endocytic route leading to MHC-II presentation is characterized to a large extent, the mechanisms controlling DC-SIGN targeted cross-presentation of exogenous peptides on MHC-I, are not completely resolved yet. In this paper, we used imaging flow cytometry and antigen-specific CD8+ T cells to investigate the intracellular fate of DC-SIGN and its cargo in human DCs. Our data demonstrates that immature DCs and toll-like receptor 4 (TLR4) stimulated DCs had similar internalization capacity and were both able to cross-present antigen targeted via DC-SIGN. Interestingly, simultaneous triggering of TLR4 and DC-SIGN on DCs resulted in the translocation of cargo to the cytosol, leading to proteasome-dependent processing and increased CD8+ T cell activation. Understanding the dynamics of DC-SIGN-mediated uptake and processing is essential for the design of optimal DC-SIGN-targeting vaccination strategies aimed at enhancing CD8+ T cell responses.

SUBMITTER: Horrevorts SK 

PROVIDER: S-EPMC6010527 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.

Horrevorts Sophie K SK   Duinkerken Sanne S   Bloem Karien K   Secades Pablo P   Kalay Hakan H   Musters René J RJ   van Vliet Sandra J SJ   García-Vallejo Juan J JJ   van Kooyk Yvette Y  

Frontiers in immunology 20180614


DC-SIGN is an antigen uptake receptor expressed on dendritic cells (DCs) with specificity for glycans present on a broad variety of pathogens and is capable of directing its cargo to MHC-I and MHC-II pathways for the induction of CD8<sup>+</sup> and CD4<sup>+</sup> T cell responses, respectively. Therefore, DC-SIGN is a very promising target for the delivery of antigen for anti-cancer vaccination. Although the endocytic route leading to MHC-II presentation is characterized to a large extent, the  ...[more]

Similar Datasets

| S-EPMC6660738 | biostudies-literature
| S-EPMC5493495 | biostudies-literature
| S-EPMC2077019 | biostudies-literature
| S-EPMC4779666 | biostudies-literature
| S-EPMC3885169 | biostudies-literature
| S-EPMC2803012 | biostudies-literature
| S-EPMC5355494 | biostudies-literature
| S-EPMC6646960 | biostudies-literature
| S-EPMC7699254 | biostudies-literature
| S-EPMC4933585 | biostudies-literature